Charlotte, North Carolina-based PeraHealth has received FDA clearance for its latest product, PeraTrend, a predictive clinical surveillance tool.
“Improving quality of patient care is our focus, which is why securing clearance from the FDA, which oversees and protects public health, is a major milestone for PeraHealth and for the clinical surveillance market,” Stephanie Alexander, PeraHealth...
Patient, provider atrial fibrillation apps launch. Two new smartphone and tablet apps targeting atrial fibrillation and designed by the European Society of Cardiology (ESC) and the University of Birmingham have launched for free on the iOS App Store and Google Play store. My AF provides patients with information about the condition, treatments, and tips on improving lifestyle, and allows patients...
